What is NDC 27241-222?

27241-222 is the product NDC for Venlafaxine, Venlafaxine hydrochloride 75 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Venlafaxine?

116 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Venlafaxine NDC 27241-222 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-222Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0222Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-222-30	27241022230	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-222-30)Marketed from Apr 12, 2023
27241-222-90	27241022290	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-222-90)Marketed from Apr 12, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Venlafaxine
Generic name (nonproprietary): venlafaxine
Active ingredients: Venlafaxine hydrochloride — 75 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Ajanta Pharma USA Inc.NDC labeler code 27241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214691
Marketing start: Apr 12, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 27241-222_a85661b9-217a-41ca-90d8-d1e29052e44dSPL ID a85661b9-217a-41ca-90d8-d1e29052e44dSPL set ID 22d4817c-1f19-4490-8a38-d8904f0374f7RxCUI 808744, 808748, 808751, 808753UNII 7D7RX5A8MOUPC 0327241222306, 0327241223303, 0327241224300, 0327241221309
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241022230 followed by a unit qualifier and the quantity

Package 27241-0222-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 27, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Venlafaxine extended-release tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) ( 1.1 ) Social Anxiety Disorder (SAD) ( 1.2 ) 1.1 Major Depressive Disorder Venlafaxine extended-release tablets are indicated for the treatment of major depressive disorder (MDD). Efficacy of venlafaxine in MDD was shown in both short-term trials and a longer-term trial in MDD [see Clinical Studies ( 14.1 )]. A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previou…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27241-222

What is NDC 27241-222?: 27241-222 is the product NDC for Venlafaxine, Venlafaxine hydrochloride 75 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Venlafaxine.
What is the active ingredient?: Venlafaxine hydrochloride.
Who is the labeler?: Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Venlafaxine?: 116 other product NDCs are listed under this name. See all Venlafaxine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Venlafaxine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
venlafaxinevenlafaxine hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	TabletOral	Coupler LLC	67046-0560	67046-0560-03
venlafaxine	Venlafaxine hydrochloride 50 mg/1	TabletOral	Coupler LLC	67046-1681	67046-1681-03
venlafaxine	Venlafaxine hydrochloride 75 mg/1	TabletOral	Coupler LLC	67046-2020	67046-2020-03
Venlafaxine	Venlafaxine hydrochloride 75 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4566	70518-4566-00
Venlafaxine	Venlafaxine hydrochloride 150 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4500	70518-4500-00
venlafaxine	Venlafaxine hydrochloride 75 mg/1	TabletOral	REMEDYREPACK INC.	70518-4168	70518-4168-00
Venlafaxine	Venlafaxine hydrochloride 75 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-3820	70518-3820-00
venlafaxinevenlafaxine hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	TabletOral	Northwind Health Company, LLC	51655-323	51655-0323-52
Venlafaxine	Venlafaxine hydrochloride 37.5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-728	60760-0728-60
Venlafaxine	Venlafaxine hydrochloride 37.5 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-221	27241-0221-3027241-0221-90

All 117 Venlafaxine NDCs

Other NDCs under ANDA 214691

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214691
Product	Strength	Form · route	Labeler	Product NDC
Venlafaxine	Venlafaxine hydrochloride 37.5 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-221
Venlafaxine	Venlafaxine hydrochloride 150 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-223
Venlafaxine	Venlafaxine hydrochloride 225 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-224